MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
November 17, 2022 18:10 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for...
$15.2 Billion Fill Finish Manufacturing Markets - Global Forecast to 2027: Opportunities in Emerging Markets
November 17, 2022 06:03 ET
|
Research and Markets
Dublin, Nov. 17, 2022 (GLOBE NEWSWIRE) -- The "Global Fill Finish Manufacturing Market" report has been added to ResearchAndMarkets.com's offering. The global fill-finish manufacturing market...
Global Monoclonal Antibodies Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunity and Forecasts
November 17, 2022 04:23 ET
|
Research and Markets
Dublin, Nov. 17, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Single Use Consumables Market by Product, Application, End User and Region - Global Forecast to 2027
November 16, 2022 08:28 ET
|
Research and Markets
Dublin, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The "Global Single Use Consumables Market by Product (Tubing, Connectors, Disconnectors, Adapters, Valves, Capsule Filter, Sensors), Application...
BiondVax Announces Plan to Implement ADS Ratio Change
November 10, 2022 16:00 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) (“BiondVax”), a biotechnology company focused on developing, manufacturing, and...
Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
November 07, 2022 16:00 ET
|
Zenas BioPharma
Proceeds to fund global Phase 3 registration program for the company’s lead product candidate, Obexelimab, and support the clinical development of other pipeline programsSeries B equity financing led...
Single-Use Bioprocess Systems Market expected to expand at a high-value CAGR of 14.4% and reach a valuation of US$ 22.2 Bn in 2032 - Persistence Market Research
November 07, 2022 09:00 ET
|
Persistence Market Research
New York, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The global single-use bioprocess systems market was worth US$ 5 Bn in 2021 and is expected to expand at a high-value CAGR of 14.4% over the forecast...
MacroGenics Provides Corporate Update and Third Quarter 2022 Financial Results
November 03, 2022 16:01 ET
|
MacroGenics, Inc.
Collaboration with Gilead to develop bispecific antibodies, including MGD024, announced Planned initiation of Phase 2 portion of MGC018 TAMARACK study in prostate cancer by year-endAnticipated update...
MacroGenics to Participate in Upcoming Investor Conferences
November 02, 2022 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Nov. 02, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for...
Global Human Microbiome Market Report 2022: Rising Focus on the Development of Therapeutics Driving Growth
November 02, 2022 06:03 ET
|
Research and Markets
Dublin, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type,...